These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19820881)

  • 1. Development of rheumatoid arthritis during the course of gefitinib therapy.
    Ohara G; Satoh H; Kohno M; Goto D; Sumida T; Hizawa N
    Sao Paulo Med J; 2009; 127(3):177-8. PubMed ID: 19820881
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis: not yet curable with early intensive therapy.
    Emery P
    Lancet; 1997 Aug; 350(9074):304-5. PubMed ID: 9251629
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of lung adenocarcinoma effectively treated with sivelestat and corcicosteroid for drug-induced lung disease due to gefitinib].
    Mori M; Iwasaki T; Nakazawa Y; Namba Y; Niinaka M; Yano Y; Kitada S; Kimura H; Naka N; Okada T; Nakagawa M; Maekura R; Yokota S
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):232-6. PubMed ID: 18409572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose prednisolone for treatment of RA.
    Kirwan J; Boers M
    Ann Rheum Dis; 2004 Nov; 63(11):1533-4; author reply 1534. PubMed ID: 15479919
    [No Abstract]   [Full Text] [Related]  

  • 5. Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report.
    Goto Y; Hojo M; Takeda Y; Kobayashi N; Kudo K
    Med Oncol; 2010 Sep; 27(3):753-5. PubMed ID: 19653137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both gefitinib and erlotinib induced drug-related interstitial lung disease in a patient with pulmonary adenocarcinoma.
    Wang KF; Chang CY; Chang SC; Liu YC; Yuan MK; Yang YH
    J Chin Med Assoc; 2013 Mar; 76(3):173-5. PubMed ID: 23497972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumatosis cystoides intestinalis after gefitinib therapy for pulmonary adenocarcinoma.
    Iwasaku M; Yoshioka H; Korogi Y; Kunimasa K; Nishiyama A; Nagai H; Ishida T
    J Thorac Oncol; 2012 Jan; 7(1):257. PubMed ID: 22173663
    [No Abstract]   [Full Text] [Related]  

  • 9. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
    Möttönen T; Hannonen P; Korpela M; Nissilä M; Kautiainen H; Ilonen J; Laasonen L; Kaipiainen-Seppänen O; Franzen P; Helve T; Koski J; Gripenberg-Gahmberg M; Myllykangas-Luosujärvi R; Leirisalo-Repo M;
    Arthritis Rheum; 2002 Apr; 46(4):894-8. PubMed ID: 11953964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
    Lian BS; Busmanis I; Lee HY
    Ann Acad Med Singap; 2018 Nov; 47(11):492-493. PubMed ID: 30578426
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment.
    Chung WP; Song HL; Ho CL; Chiu NT; Su WC
    J Clin Oncol; 2013 Jan; 31(1):e6-8. PubMed ID: 23169516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alveolar hemorrhage as a possible adverse drug reaction by gefitinib (ZD1839, Iressa)].
    Ieki R; Saitoh E; Hashimoto E; Ohta T; Yuasa K; Iguchi M; Okamura T; Shibuya M; Moriyama S; Goto H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):977-80. PubMed ID: 12894713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual terminal hair growth on the nose tip associated with gefitinib therapy.
    Kim SY; Choi HJ; Park HJ; Lee JY; Cho BK
    Br J Dermatol; 2007 May; 156(5):1087-8. PubMed ID: 17388923
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous bilateral spontaneous pneumothorax observed during the administration of gefitinib for lung adenocarcinoma with multiple lung metastases.
    Mori M; Nakagawa M; Fujikawa T; Iwasaki T; Kawamura T; Namba Y; Niinaka M; Takeda Y; Kimura H; Naka N; Okada T; Yamaguchi T; Yokota S; Ito M
    Intern Med; 2005 Aug; 44(8):862-4. PubMed ID: 16157988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute interstitial pnuemonia and gefitinib.
    Sumpter K; Harper-Wynne C; O'Brien M; Congleton J
    Lung Cancer; 2004 Mar; 43(3):367-8. PubMed ID: 15165098
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib.
    Maruyama K; Chinda J; Kuroshima T; Kabara M; Nakagawa N; Fujino T; Yamamoto Y; Ohsaki Y; Ogawa Y; Hasebe N
    Intern Med; 2015; 54(7):823-6. PubMed ID: 25832950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.